Who makes 13C5-Calcium-L-Leucovorin?

13C5-Calcium-L-Leucovorin is developed by The Hospital for Sick Children.

What development phase is 13C5-Calcium-L-Leucovorin in?

13C5-Calcium-L-Leucovorin is in Phase 1.

Last reviewed 2026-05-15 · How we verify

13C5-Calcium-L-Leucovorin

The Hospital for Sick Children · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	13C5-Calcium-L-Leucovorin
Also known as	13C5 Folate
Sponsor	The Hospital for Sick Children
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Folate Absorption Across the Large Intestine (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

13C5-Calcium-L-Leucovorin CI brief — competitive landscape report
13C5-Calcium-L-Leucovorin updates RSS · CI watch RSS
The Hospital for Sick Children portfolio CI